<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Amylyx Pharmaceuticals, Inc. (AMLX) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/amlx/filings</link>
    <description>Latest company filings for Amylyx Pharmaceuticals, Inc. (AMLX) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sat, 11 Jul 2026 21:53:14 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/amlx/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526239216/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-239216</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-05-26.]]></description>
      <pubDate>Tue, 26 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526226565/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-226565</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526210292/amlx-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-210292</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Quarterly report (10-Q) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526210286/amlx-20260507.htm</link>
      <guid isPermaLink="false">0001193125-26-210286</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Major company event (8-K) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526171809/amlx-ars-2026.pdf</link>
      <guid isPermaLink="false">0001193125-26-171809</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Annual report to shareholders (ARS) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526171803/amlx-defa14a-2026-additi.htm</link>
      <guid isPermaLink="false">0001193125-26-171803</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Proxy materials (DEFA14A) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm</link>
      <guid isPermaLink="false">0001193125-26-171800</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Proxy statement (DEF 14A) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[AMLX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000010290926000598/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-000598</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-26.]]></description>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526120691/d49067d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-120691</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Major company event (8-K) on 2026-03-24.]]></description>
      <pubDate>Tue, 24 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526098440/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-098440</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526098439/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-098439</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526098438/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-098438</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526098437/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-098437</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526098436/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-098436</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526091443/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-091443</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526091442/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-091442</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526091440/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-091440</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526091438/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-091438</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526091436/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-091436</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526088117/d102493ds8.htm</link>
      <guid isPermaLink="false">0001193125-26-088117</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Employee stock plan (S-8) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[AMLX: S-3ASR]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526086735/d82596ds3asr.htm</link>
      <guid isPermaLink="false">0001193125-26-086735</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a S-3ASR (S-3ASR) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-3ASR</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526086645/amlx-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-086645</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Annual report (10-K) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526086629/amlx-20260303.htm</link>
      <guid isPermaLink="false">0001193125-26-086629</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Major company event (8-K) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000191376526000002/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001913765-26-000002</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000189864426000002/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001898644-26-000002</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000189831426000002/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001898314-26-000002</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000132696926000002/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001326969-26-000002</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000123559826000002/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001235598-26-000002</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526071460/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-071460</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-02-25.]]></description>
      <pubDate>Wed, 25 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526064078/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-064078</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526054741/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-054741</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AMLX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000090266426000907/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-26-000907</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-12.]]></description>
      <pubDate>Thu, 12 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AMLX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000031506626000374/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000315066-26-000374</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-05.]]></description>
      <pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526037553/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-037553</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526037552/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-037552</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526037548/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-037548</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526037544/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-037544</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526033641/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-033641</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526033640/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-033640</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526033639/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-033639</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526033638/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-033638</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000010290926000077/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-000077</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-01-30.]]></description>
      <pubDate>Fri, 30 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AMLX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000201238326000638/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002012383-26-000638</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526017057/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-017057</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-01-20.]]></description>
      <pubDate>Tue, 20 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526017056/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-017056</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-01-20.]]></description>
      <pubDate>Tue, 20 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000195004726000500/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000500</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-01-16.]]></description>
      <pubDate>Fri, 16 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000195004726000499/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000499</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-01-16.]]></description>
      <pubDate>Fri, 16 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000195004726000451/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000451</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-01-15.]]></description>
      <pubDate>Thu, 15 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000195004726000449/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000449</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider sale notice (144) on 2026-01-15.]]></description>
      <pubDate>Thu, 15 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AMLX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1658551/000119312526012921/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-012921</guid>
      <description><![CDATA[Amylyx Pharmaceuticals, Inc. filed a Insider trade (4) on 2026-01-14.]]></description>
      <pubDate>Wed, 14 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
  </channel>
</rss>